These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 15660698

  • 1. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
    Awaya H, Takeshima Y, Amatya VJ, Ishida H, Yamasaki M, Kohno N, Inai K.
    Pathol Int; 2005 Jan; 55(1):14-8. PubMed ID: 15660698
    [Abstract] [Full Text] [Related]

  • 2. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
    Hidaka N, Nagao T, Asoh A, Kondo Y, Nagao K.
    Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR, Fonsechi-Carvasan GA, De Angelo Andrade LA, Böttcher-Luiz F.
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [Abstract] [Full Text] [Related]

  • 8. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR.
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
    Clavel CE, Nollet F, Berx G, Tejpar S, Nawrocki-Raby B, Kaplan HH, van Roy FM, Birembaut PL.
    J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
    Zhou YN, Li M.
    Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
    [Abstract] [Full Text] [Related]

  • 15. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer.
    Kojima M, Shiokawa A, Ohike N, Tamegai Y, Kato H, Morohoshi T.
    Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ, Jang SJ, Yu E.
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [Abstract] [Full Text] [Related]

  • 18. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ, Zhou QH, Zhang SF, Liu LX.
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
    Fujioka T, Takebayashi Y, Kihana T, Kusanagi Y, Hamada K, Ochi H, Uchida T, Fukumoto M, Ito M.
    Oncol Rep; 2001 May; 8(2):249-55. PubMed ID: 11182035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.